Provided by Tiger Trade Technology Pte. Ltd.

GoodRx Holdings, Inc.

3.45
-0.1100-3.09%
Post-market: 3.480.0277+0.80%19:54 EDT
Volume:1.75M
Turnover:6.11M
Market Cap:1.18B
PE:72.68
High:3.60
Open:3.60
Low:3.44
Close:3.56
52wk High:5.81
52wk Low:1.77
Shares:341.15M
Float Shares:93.82M
Volume Ratio:0.81
T/O Rate:1.86%
Dividend:- -
Dividend Rate:- -
EPS(TTM):0.0475
EPS(LYR):0.0854
ROE:2.52%
ROA:3.05%
PB:1.82
PE(LYR):40.39

Loading ...

Francisco Partners IV, L.P. Reports Disposal of 1,193,951 GoodRx Common Shares for $4.2 Million

Reuters
·
Yesterday

GoodRx price target raised to $4 from $3 at Barclays

TIPRANKS
·
Aug 21

'It Feels Like a Medical Miracle': How Did a Single QR Code Coupon Cut My $618 Walgreens Prescription to $15?

Dow Jones
·
Aug 14

GoodRx Holdings is Maintained at Neutral by UBS

Dow Jones
·
Aug 14

GoodRx Files Form 3 for CFO, Chief Strategy & Operations Officer Justin Fengler

Reuters
·
Aug 13

GoodRx Holdings Price Target Raised to $5.00/Share from $4.00 by Citigroup

Dow Jones
·
Aug 12

GoodRx Earnings Call Signals Pivot To Growth Engines

TIPRANKS
·
Aug 11

Morgan Stanley Adjusts Price Target on GoodRx to $4 From $3, Maintains Equalweight Rating

MT Newswires Live
·
Aug 07

GoodRx (GDRX) Stock Jumps As Margins Strengthen And User Declines Linger

Simply Wall St.
·
Aug 07

Doximity Q1 Revenue Beats Analyst Estimates

Reuters
·
Aug 07

GoodRx price target raised to $5 from $3.50 at Leerink

TIPRANKS
·
Aug 07

Analysts’ Opinions Are Mixed on These Healthcare Stocks: GoodRx Holdings (GDRX), Xencor (XNCR) and PepGen Inc. (PEPG)

TIPRANKS
·
Aug 06

GoodRx Holdings, Inc. Reports Results for the Quarter Ended June 30 - Earnings Summary

Reuters
·
Aug 06

GoodRx Names Chief Strategy and Operations Officer Justin Fengler as CFO, Succeeding Christopher McGinnis

Reuters
·
Aug 06

GoodRx Q2 Net Income Falls 34% to $8.5 Million; Revenue Slips 1% to $200.4 Million

Reuters
·
Aug 06

GoodRx - Christopher Mcginnis to Step Down as CFO & Treasurer Effective August 5, 2026 - SEC Filing

THOMSON REUTERS
·
Aug 06

GoodRx Holdings Q2 Adj. EPS $0.08, Inline, Sales $200.411M Beat $193.162M Estimate

Benzinga Earnings
·
Aug 06

GoodRx Holdings Q2 Adjusted Net Income USD 26.8 Million Vs. IBES Estimate USD 27.2 Million

Reuters
·
Aug 06

GoodRx Holdings, Inc. Fy2026 REV View $775.8 Mln

THOMSON REUTERS
·
Aug 06

GoodRx Holdings Outlook FY 2026 Adjusted Ebitda $240 - $250 Million

THOMSON REUTERS
·
Aug 06